Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Argentinian (MERVAL) Pharma Industry Analysis

UpdatedAug 17, 2026
DataAggregated Company Financials
Companies1
  • 7D1.3%
  • 3M-2.2%
  • 1Y21.0%
  • YTD-22.1%

Over the last 7 days, the Pharma industry has remained flat. As for the the longer term, the industry is up 21% over the past 12 months.

Industry Valuation and Performance

Has the Argentinian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Aug 2026AR$125.6bAR$114.0bAR$13.0b9.6x9.6x1.1x
Wed, 15 Jul 2026AR$126.0bAR$119.6bAR$16.1b7.7x7.8x1.1x
Fri, 12 Jun 2026AR$128.8bAR$119.6bAR$16.1b8.2x8x1.1x
Sun, 10 May 2026AR$130.0bAR$126.7bAR$2.4b54.7x54.1x1x
Tue, 07 Apr 2026AR$143.2bAR$130.8b-AR$1,946,644,487.0056.8x-73.6x1.1x
Thu, 05 Mar 2026AR$139.5bAR$107.5b-AR$10,024,883,532.00n/a-13.9x1.3x
Sat, 31 Jan 2026AR$177.4bAR$107.5b-AR$10,024,883,532.00n/a-17.7x1.7x
Mon, 29 Dec 2025AR$168.3bAR$108.5b-AR$8,970,776,885.00n/a-18.8x1.6x
Wed, 26 Nov 2025AR$156.9bAR$108.5b-AR$8,970,776,885.00n/a-17.5x1.4x
Fri, 24 Oct 2025AR$98.0bAR$103.2bAR$8.2b8.4x11.9x0.9x
Sun, 21 Sep 2025AR$84.8bAR$104.5bAR$9.0b6.8x9.4x0.8x
Tue, 19 Aug 2025AR$112.1bAR$104.5bAR$9.0b8.9x12.4x1.1x
Thu, 17 Jul 2025AR$122.0bAR$102.7bAR$16.3b6.1x7.5x1.2x
Sat, 14 Jun 2025AR$130.8bAR$104.7bAR$17.4b6.2x7.5x1.2x
Mon, 12 May 2025AR$119.0bAR$100.1bAR$22.4b4.8x5.3x1.2x
Wed, 09 Apr 2025AR$120.1bAR$97.1bAR$23.7b4.8x5.1x1.2x
Fri, 07 Mar 2025AR$146.1bAR$42.6bAR$18.2b6.4x8x3.4x
Sun, 02 Feb 2025AR$138.1bAR$42.6bAR$18.2b6.3x7.6x3.2x
Tue, 31 Dec 2024AR$142.6bAR$42.6bAR$18.2b6.8x7.8x3.3x
Thu, 28 Nov 2024AR$151.2bAR$42.6bAR$18.2b6.4x8.3x3.5x
Sat, 26 Oct 2024AR$104.7bAR$40.7bAR$4.6b16.9x23x2.6x
Mon, 23 Sep 2024AR$77.6bAR$40.7bAR$4.6b12.8x17x1.9x
Wed, 21 Aug 2024AR$86.7bAR$52.7bAR$2.3b33.9x38.4x1.6x
Fri, 19 Jul 2024AR$77.9bAR$41.1b-AR$3,264,658,797.004.5x-23.9x1.9x
Sun, 16 Jun 2024AR$85.6bAR$41.1b-AR$3,264,658,797.004.9x-26.2x2.1x
Tue, 14 May 2024AR$75.2bAR$43.6b-AR$10,287,966,966.009.2x-7.3x1.7x
Thu, 11 Apr 2024AR$81.8bAR$40.2b-AR$10,767,928,257.0054.9x-7.6x2x
Sat, 09 Mar 2024AR$69.9bAR$9.6b-AR$4,702,241,388.0045.2x-14.9x7.2x
Mon, 05 Feb 2024AR$96.6bAR$10.3b-AR$4,704,193,685.0058.1x-20.5x9.3x
Wed, 03 Jan 2024AR$57.5bAR$10.3b-AR$4,704,193,685.0033.4x-12.2x5.6x
Fri, 01 Dec 2023AR$56.4bAR$10.3b-AR$4,704,193,685.0031x-12x5.4x
Sun, 29 Oct 2023AR$58.0bAR$13.0b-AR$2,496,856,221.00n/a-23.2x4.4x
Tue, 26 Sep 2023AR$43.3bAR$13.0b-AR$2,496,856,221.00n/a-17.3x3.3x
Thu, 24 Aug 2023AR$47.8bAR$18.8b-AR$150,001,147.0015.3x-318.8x2.5x
Price to Earnings Ratio

-318.8x


Total Market Cap: AR$47.8bTotal Earnings: -AR$150,001,147.00Total Revenue: AR$18.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Argentinian Pharma Industry Price to Earnings3Y Average -11.1x202420252026
Current Industry PE
    There is only one company in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 88% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Argentinian Healthcare industry?

AR Market-2.77%
Healthcare1.30%
Pharma1.30%
Pharma1.30%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RICH Laboratorios RichmondC.I.FAR$1.56k1.3%
+AR$1.6b		21.0%PE9.6x

Latest News

ROSE
AR$156.00
Instituto Rosenbusch
7D
-1.6%
1Y
-20.2%
RICH
AR$1,555.00
Laboratorios RichmondC.I.F
7D
1.3%
1Y
21.0%